LSoucekLab retweeted
🎗️ En el #DíaMundialContraElCáncerDeMama, recuperamos las charlas y talleres para pacientes con #CáncerDeMama, organizadas junto a @ChicEndavant y @vallhebron
💻 Un espacio para abordar los tratamientos y los aspectos físicos, emocionales y sociales de la enfermedad.
▶️ Disponibles en nuestro canal de #YouTube 👉 youtube.com/playlist?list=PL…
#MamaVHIO #VHIODivulga
LSoucekLab retweeted
💬 “Los resultados que creamos aquí en los laboratorios van a poderse pasar rápidamente a los pacientes.”
Iñigo González, investigador postdoctoral del Grupo de Modelización de Terapias Antitumorales, y Jordi Martínez-Quintanilla, investigador sénior del Grupo de Células Madre y Cáncer, reflexionan sobre la colaboración entre grupos, el vínculo con la clínica y el futuro de la investigación traslacional en VHIO.
▶️ Vídeo completo en YouTube
➕ 20anys.vhio.net
#20VHIO @vallhebron @ignigor
LSoucekLab retweeted
🔬 Our 2025 Scientific Report is now out‼️ Driving progress through disruptive science and clinical innovation in oncology. 🚀
🔗 Read the full report 👉 linke.to/VHIOScientificRepor…
LSoucekLab retweeted
🔝 #VHIO renova l'acreditació com a Centre d'Excel·lència Severo Ochoa, consolidant el nostre lideratge en recerca oncològica i aposta per transformar la ciència en noves oportunitats per als pacients.
👏 Un reconeixement a totes les persones que fan possible el VHIO. Gràcies‼️
➡️ linke.to/ReacreditacionSever…
#SOMMVhio
LSoucekLab retweeted
📣 New VHIO-@CaixaResearch Scientific Seminar‼️
🔹 Targeting clonal heterogeneity in treatment-refractory Glioblastoma with novel and empiric immunotherapies
👩🔬 @sheilasinghlab, Head of the School of Cancer & Pharmaceutical Sciences and Director of the Comprehensive Cancer Centre @KingsCollegeLon & Professor at @EvelinaLondon @GSTTnhs
🗓 Friday, 19th June at 12h
🎤 Host: @LauraSoucek
Register at 👉 [email protected]
LSoucekLab retweeted
📣 New VHIO-@CaixaResearch Scientific Seminar‼️
🔹 Targeting clonal heterogeneity in treatment-refractory Glioblastoma with novel and empiric immunotherapies
👩🔬 @sheilasinghlab, Head of the School of Cancer & Pharmaceutical Sciences and Director of the Comprehensive Cancer Centre @KingsCollegeLon & Professor at @EvelinaLondon @GSTTnhs
🗓 Friday, 19th June at 12h
🎤 Host: @LauraSoucek
Register at 👉 [email protected]
LSoucekLab retweeted
For years, #RAS and #MYC were considered "undruggable." The success of RAS has changed the conversation. Proud to see this recent @Nature News & Views highlighting MYC as a promising next frontier and @Peptomyc as a key player helping advance the field. nature.com/articles/d41586-0…
LSoucekLab retweeted
Exciting news for patients and for the oncology community. The Phase 3 #daraxonrasib results in mPDAC show once again that pursuing challenging targets can lead to meaningful clinical advances and that ambitious science is worth the effort.
nejm.org/doi/full/10.1056/NE…
#RASi #MYCi
LSoucekLab retweeted
Enhorabona!
🇪🇺🔬L'@ERC_Research concedeix subvencions a 17 beneficiaris a Catalunya i 1 a les Balears.
Són ajuts a la recerca científica per avaluar el potencial d’innovació en aplicacions comercials i socials en medecina, geologia, bioenginyeria, entre altres.
🔗link.europa.eu/DGckqB
LSoucekLab retweeted
I always try to say yes to student invitations—my small way to feed forward and support the next generation in science.
Huge thanks to the PhD students who organized the event—fantastic job! Despite train delays and a very late return home, it was absolutely worth it 😊
LSoucekLab retweeted
Last Friday I was an invited speaker at the PhD Day of @IIBM_CSIC / CSIC-UAM / CIBERER / IdiPaz in Madrid.
I talked about the journey toward a clinically viable MYC inhibitor and my path as a researcher (@VHIO, @icreacommunity, @LSoucekLab) and entrepreneur (@peptomyc).
LSoucekLab retweeted
🗞️Una revisió publicada a @FrontCellDevBio
amb participació de l'#investigadorICREA @LauraSoucek (@VHIO @peptomyc), analitza com la combinació d'inhibidors oncogènics MYC amb teràpies dirigides obre noves oportunitats terapèutiques.
frontiersin.org/journals/cel…
LSoucekLab retweeted
🎉 New review in @FrontCellDevBio: #MYC in DNA damage response (#DDR) — driver of genomic instability and DNA repair.
Key idea: #MYC inhibition → DDR vulnerabilities → rational combos (#PARP, ATR/CHK1, WEE1).
🔗 frontiersin.org/journals/cel…
#MYC #DDR @VHIO @peptomyc @icreacommunity
LSoucekLab retweeted
Ayer @LauraSoucek , nuestra CSO, participó como Keynote Speaker en la 19ª Jornada Científica y 29ª Conferencia Anual del Hospital Vall d’Hebron ✨
Agradecemos al @vallhebron por crear un espacio de intercambio tan enriquecedor.
shorturl.at/Bd8Fl
#MYC #KeynoteSpeaker
LSoucekLab retweeted
Un estudi coliderat per la #investigadoraICREA @LauraSoucek (@LSoucekLab) mostra que Omomyc —el fàrmac creat per la spin-off d'ICREA i VHIO @peptomyc— pot ser una estratègia terapèutica per combatre el càncer de mama triple negatiu.
🔗Consulta la notícia: bit.ly/4pRdY6P
🧬 Publicat a @CellReports: combinar l’inhibidor de MYC Omomyc amb teràpies dirigides a la reparació de l’ADN potencia l’activitat antitumoral en models preclínics de càncer de mama triple negatiu.
🗞️ L’estudi està liderat per @LauraSoucek i Fabio Giuntini, del grup de Modelització de Teràpies Antitumorals del VHIO.
@peptomyc, l’spin-off del VHIO i @icreacommunity, ha desenvolupat Omomyc.
➕ linke.to/OmomycVHIO_Cat
LSoucekLab retweeted
🧬 Publicado en @CellReports: Combinar el inhibidor de MYC Omomyc con terapias dirigidas a la reparación del ADN potencia la actividad antitumoral en modelos preclínicos de #cáncerdemamatriplenegativo.
🗞️ El estudio está liderado por @LauraSoucek y Fabio Giuntini, del grupo de Modelización de Terapias Antitumorales del VHIO.
@peptomyc, spin-off del VHIO e @icreacommunity, ha desarrollado Omomyc.
➕ linke.to/OmomycVHIO_Cast
LSoucekLab retweeted
🔴 Recently published in @CellReports, a #VHIO-led study led by @LauraSoucek and Fabio Giuntini shows that combining the MYC inhibitor #Omomyc with DNA-repair–targeted therapies boosts anti-tumor activity in preclinical triple-negative #breastcancer. Omomyc was developed by @peptomyc, the VHIO & @icreacommunity spin-off.
➡️ linke.to/OmomycVHIO
LSoucekLab retweeted
Encantada de participar en el Ennova Health Day representando a @VHIO, @icreacommunity y @Peptomyc. Gracias a la organización, @DiarioMedico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.
LSoucekLab retweeted
Researchers @LauraSoucek and Francisco Barriga (@BarrigaLabVHIO) join the 2nd Botton-Champalimaud Pancreatic Cancer Conference held in Lisbon — a pivotal platform to exchange groundbreaking insights and innovative therapies to advance patient care worldwide.
#PancreaticCancer
LSoucekLab retweeted
The @FundacionBBVA – #VHIO International Master’s Internship Programme is now OPEN‼️
6️⃣ positions for life sciences Master’s students to complete their thesis at a leading Translational Research Center of Excellence 👉 linke.to/MasterInterProgramm…
🗓 Deadline: Dec 2, 2025
#SOMMVHIO
